|
- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30441
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Review
Hepatocyte cell therapy in liver disease
Posted online on July 27, 2015.
David Christopher Bartlett, and Philip N Newsome
NIHR Centre for Liver Research and Biomedical Research Unit, University of Birmingham, Birmingham,
UK
Liver Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham,
UK
*Author for correspondence: [email protected]
Liver disease is a leading cause of morbidity and mortality. Liver transplantation remains the only proven treatment for end-stage liver failure but is limited by the availability of donor organs. Hepatocyte cell therapy, either with bioartificial liver devices or hepatocyte transplantation, may help address this by delaying or preventing liver transplantation. Early clinical studies have shown promising results, however in most cases, the benefit has been short lived and so further research into these therapies is required. Alternative sources of hepatocytes, including stem cell-derived hepatocytes, are being investigated as the isolation of primary human hepatocytes is limited by the same shortage of donor organs. This review summarises the current clinical experience of hepatocyte cell therapy together with an overview of possible alternative sources of hepatocytes. Current and future areas for research that might lead towards the realisation of the full potential of hepatocyte cell therapy are discussed.
Keywords
acute liver failure, bioartificial liver device, cell therapy, hepatocyte cell therapy, hepatocyte transplantation, inborn errors of metabolism, liver failure
Read More: http://informahealthcare.com/doi ... 474124.2015.1073106
|
|
发表于 2015-7-28 14:59